21050 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Protease inhibitors
Prevention and reduction of blood loss
#302Use of SERP-1 as an antiplatelet agent
#303Prevention and reduction of blood loss
#304Treatment of Patients with Cystic Disease by Alteration of Fibrocystin Proteolysis
#305Potentiation of the immune response
#306Methods for inhibiting pain
#307Method for inhibiting apoptosis through the p75 neurotrophin receptor
#308Therapeutic agents for low HDL-cholesterolemia
#309Treatment of an Intestinal Adenoma and/or Adenocarcinoma by Inhibition of Notch Pathway Activation
#310Agents for the treatment of viral infections
#311Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
#312Proteins Involved in Signal Transduction
#313Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
#314Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
#315Formulations for ecallantide
#316Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#317Apoptosis inhibitors
#318Dynamin mediated diseases and associated methods and products
#319Method of cancer treatment by p53 protein control
#320Non-glycerol stabilized bone graft
#321Hair tonics and method of screening the same
#322Formulation to improve survival of transplanted cells
#323Hematopoietic stimulation
#324Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
#325Method of regulating glucose metabolism, and reagents related thereto
#326Anti-inflammatory, cytoprotective factor derivable from a probiotic organism
#327Compounds for enzyme inhibition
#328Therapeutic agent for iNOS generating illness
#329Anti-chrondrosarcoma compounds
#330Glycogen synthase kinase-3 inhibitors
#331Macrocyclic inhibitors of hepatitis C virus replication
#332Use of Insulin for the Treatment of Cartilaginous Disorders
#333Proteaseome inhibitors for the treatment of herpesviridae infected individuals
#334Kit comprising elastase
#335Methods for using an elastase
#336Therapeutic agents for low HDL-cholesterolemia
#337Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
#338Method for treating amyloid disease
#339Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#340Remedy for eye diseases accompanied by optic nerve injuries
#341Nematode-extracted serine protease inhibitors and anticoagulant proteins
#342Inhibiting furin with polybasic peptides
#343Calpains as targets for inhibition of prion propagation
#344Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
#345Controlled release liposomes and methods of use
#346Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors
#347Methods for increasing cell and tissue viability
#348Prevention and reduction of blood loss
#349Modulation of plasma membrane Human Leukocyte Elastase
#350Hair tonics and method of screening the same
#351Therapeutic agents for low HDL-cholesterolemia
#352Use of SERP-1 as an antiplatelet agent
#353Drug for preventing, regulating or treating adhesion
#354Methods, compositions and kits for treating damage to excitable tissue
#355Treatment of pain by inhibition of caspase signaling
#356Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#357Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
#358Use of enzyme inhibitors of aminopeptidase N and/or dipeptidylpeptidase IV
#359Drug therapy for Celiac Sprue
#360Compositions and methods for treating and preventing necrosis
#361Glue composition for lung volume reduction
#362Targeting sites of damaged lung tissue
#363Targeting damaged lung tissue using compositions
#364Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
#365Treating infectious diseases using ice inhibitors
#366Compositions and methods for inhibiting abnormal cell growth
#367Nematode-extracted serine protease inhibitors and anticoagulant proteins
#368Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#369Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
#370Proteaseome inhibitors for the treatment of herpesviridae infected individuals
#371Methods for preserving the viability of photoreceptor cells by anti-FAS-ligand/anti-FAS-receptor antibodies
#372Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#373Drug delivery to the inner ear and methods of using same
#374Suppression of immune response via inhibition of cathepsin S
#375Inhibitors of PACE4 for the treatment of arthritis
#376Drugs ameliorating hypo-hdl cholesterolemia
#377Suppression of immune response via inhibition of cathepsin S
#378Hematopoietic stimulation
#379Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
#380Combinations of enzyme inhibitor-containing preparations and the use thereof
#381Potentiation of the immune response
#382Methods of treating Pin1 associated disorders by covalent modification of active site residues
#383Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#384Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
#385Protease inhibitor:protease sensitive expression system, composition and methods for improving the therapeutic activity and specificity of proteins delivered by bacteria
#386Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
#387Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#388Protease inhibitor combination with therapeutic proteins including antibodies
#389Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
#390Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#391Protease inhibitor: protease sensitive expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
#392Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
#393Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
#394Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria
#395Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
#396Protease inhibitor combination with therapeutic proteins including antibodies